Astrocytes and lysosomal storage diseases

Neuroscience

Volumn 323, Issue , 2016, Pages 195-206

  Rama Rao, K V ^a   Kielian, T ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Astrocytes; Lysosomal storage diseases; Mitochondrial dysfunction; Neurodegeneration; Reactive astrocytosis

Indexed keywords

CATHEPSIN D; INTERLEUKIN 6; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR 1; PROSTAGLANDIN RECEPTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG;

ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL FUNCTION; CELL LOSS; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME PHOSPHORYLATION; GAUCHER DISEASE; GENE EXPRESSION; GLOBOID CELL LEUKODYSTROPHY; HUMAN; LYSOSOME STORAGE DISEASE; MULTIPLE SULFATASE DEFICIENCY; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPATHOLOGY; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SANDHOFF DISEASE; ANIMAL; DEGENERATIVE DISEASE; GENETICS; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ASTROCYTES; HUMANS; LYSOSOMAL STORAGE DISEASES; NEURODEGENERATIVE DISEASES; NEURONS;

EID: 84930905283     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.05.061     Document Type: Review

References (175)

1. Aberg L., Lauronen L., Hamalainen J., Mole S.E., Autti T. A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course. Pediatr Neurol 2009, 40:134-137.
2. Aberg L., Liewendahl K., Nikkinen P., Autti T., Rinne J.O., Santavuori P. Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms. Neurology 2000, 54:1069-1074.
3. Abo-Ouf H., Hooper A.W., White E.J., van Rensburg H.J., Trigatti B.L., Igdoura S.A. Deletion of tumor necrosis factor-alpha ameliorates neurodegeneration in Sandhoff disease mice. Hum Mol Genet 2013, 22:3960-3975.
4. Abudara V., Bechberger J., Freitas-Andrade M., De Bock M., Wang N., Bultynck G., Naus C.C., Leybaert L., Giaume C. The connexin43 mimetic peptide Gap19 inhibits hemichannels without altering gap junctional communication in astrocytes. Front Cell Neurosci 2014, 8:306.
5. Abudara V., Roux L., Dallerac G., Matias I., Dulong J., Mothet J.P., Rouach N., Giaume C. Activated microglia impairs neuroglial interaction by opening Cx43 hemichannels in hippocampal astrocytes. Glia 2015, 63:795-811.
6. Alroy J., Adelman L.S., Warren C.D. Lectin histochemistry of gangliosidosis. II. Neurovisceral tissues from patients with Sandhoff's disease. Acta Neuropathol 1988, 76:359-365.
7. Andrews J.M., Cancilla P.A. Cytoplasmic inclusions in human globoid cell leukodystrophy. Krabbe's disease. Arch Pathol 1970, 89:53-55.
8. Andrews J.M., Cancilla P.A., Grippo J., Menkes J.H. Globoid cell leukodystrophy (Krabbe's disease): morphological and biochemical studies. Neurology 1971, 21:337-352.
9. Annunziata I., Bouche V., Lombardi A., Settembre C., Ballabio A. Multiple sulfatase deficiency is due to hypomorphic mutations of the SUMF1 gene. Hum Mutat 2007, 28:928.
10. Appel M.F., Markowitz A.M. Massive splenomegaly in Gaucher's disease. JAMA 1971, 217:343-344.
11. Araque A., Carmignoto G., Haydon P.G., Oliet S.H., Robitaille R., Volterra A. Gliotransmitters travel in time and space. Neuron 2014, 81:728-739.
12. Austin J.H. Studies in metachromatic leukodystrophy. XII. Multiple sulfatase deficiency. Arch Neurol 1973, 28:258-264.
13. Bassi R., Anelli V., Giussani P., Tettamanti G., Viani P., Riboni L. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors. Glia 2006, 53:621-630.
14. Bezzi P., Domercq M., Vesce S., Volterra A. Neuron-astrocyte cross-talk during synaptic transmission: physiological and neuropathological implications. Prog Brain Res 2001, 132:255-265.
15. Blunt S.B., Jenner P., Marsden C.D. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa. Exp Brain Res 1992, 88:326-340.
16. Bosch M., Kielian T. Hemichannels in neurodegenerative diseases: is there a link to pathology?. Front Cell Neurosci 2014, 8:242.
17. Boustany R.M. Lysosomal storage diseases - the horizon expands. Nat Rev Neurol 2013, 9:583-598.
18. Brinkmann V. FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system. Br J Pharmacol 2009, 158:1173-1182.
19. Bruun I., Reske-Nielsen E., Oster S. Juvenile ceroid-lipofuscinosis and calcifications of the CNS. Acta Neurol Scand 1991, 83:1-8.
20. Burda J.E., Sofroniew M.V. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 2014, 81:229-248.
21. Burk R.D., Valle D., Thomas G.H., Miller C., Moser A., Moser H., Rosenbaum K.N. Early manifestations of multiple sulfatase deficiency. J Pediatr 1984, 104:574-578.
22. Burkovetskaya M., Karpuk N., Xiong J., Bosch M., Boska M.D., Takeuchi H., Suzumura A., Kielian T. Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL). PLoS One 2014, 9:e95023.
23. Busche A., Hennermann J.B., Burger F., Proquitte H., Dierks T., von Arnim-Baas A., Horn D. Neonatal manifestation of multiple sulfatase deficiency. Eur J Pediatr 2009, 168:969-973.
24. Calatayud C.A., Pasquini L.A., Pasquini J.M., Soto E.F. Involvement of the ubiquitin-mediated proteolytic system in the signaling pathway induced by ceramide in primary astrocyte cultures. Dev Neurosci 2005, 27:397-407.
25. Cantuti Castelvetri L., Givogri M.I., Hebert A., Smith B., Song Y., Kaminska A., Lopez-Rosas A., Morfini G., Pigino G., Sands M., Brady S.T., Bongarzone E.R. The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3beta and deregulation of molecular motors. J Neurosci 2013, 33:10048-10056.
26. Castelvetri L.C., Givogri M.I., Zhu H., Smith B., Lopez-Rosas A., Qiu X., van Breemen R., Bongarzone E.R. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol 2011, 122:35-48.
27. 2+ homeostasis, autophagy, and CLN3 function. J Biol Chem 2015, 290:14361-14380.
28. Chen C.S., Patterson M.C., Wheatley C.L., O'Brien J.F., Pagano R.E. Broad screening test for sphingolipid-storage diseases. Lancet 1999, 354:901-905.
29. Choi S.H., Choi D.H., Lee J.J., Park M.S., Chun B.G. Imidazoline drugs stabilize lysosomes and inhibit oxidative cytotoxicity in astrocytes. Free Radic Biol Med 2002, 32:394-405.
30. Chun J., Brinkmann V. A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya). Discov Med 2011, 12:213-228.
31. Coleman R.J., Robb S.A., Lake B.D., Brett E.M., Harding A.E. The diverse neurological features of Niemann-Pick disease type C: a report of two cases. Mov Disord 1988, 3:295-299.
32. Conradi N.G., Kalimo H., Sourander P. Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol 1988, 75:385-390.
33. Conradi N.G., Sourander P., Nilsson O., Svennerholm L., Erikson A. Neuropathology of the Norrbottnian type of Gaucher disease. Morphological and biochemical studies. Acta Neuropathol 1984, 65:99-109.
34. Cotman S.L., Karaa A., Staropoli J.F., Sims K.B. Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum. Curr Neurol Neurosci Rep 2013, 13:366.
35. Cox T.M., Cachon-Gonzalez M.B. The cellular pathology of lysosomal diseases. J Pathol 2012, 226:241-254.
36. De Duve C. The lysosome. Sci Am 1963, 208:64-72.
37. De Duve C. The significance of lysosomes in pathology and medicine. Proc Inst Med Chic 1966, 26:73-76.
38. de Pablo-Latorre R., Saide A., Polishhuck E.V., Nusco E., Fraldi A., Ballabio A. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum Mol Genet 2012, 21:1770-1781.
39. Deng H., Xiu X., Jankovic J. Genetic convergence of Parkinson's disease and lysosomal storage disorders. Mol Neurobiol 2015, 51:1554-1568.
40. Di Malta C., Fryer J.D., Settembre C., Ballabio A. Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. Proc Natl Acad Sci U S A 2012, 109:E2334-2342.
41. Di Malta C., Fryer J.D., Settembre C., Ballabio A. Autophagy in astrocytes: a novel culprit in lysosomal storage disorders. Autophagy 2012, 8:1871-1872.
42. Diaz-Font A., Santamaria R., Cozar M., Blanco M., Chamoles N., Coll M.J., Chabas A., Vilageliu L., Grinberg D. Clinical and mutational characterization of three patients with multiple sulfatase deficiency: report of a new splicing mutation. Mol Genet Metab 2005, 86:206-211.
43. Enquist I.B., Lo Bianco C., Ooka A., Nilsson E., Mansson J.E., Ehinger M., Richter J., Brady R.O., Kirik D., Karlsson S. Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci U S A 2007, 104:17483-17488.
44. Episcopo F.L., Tirolo C., Testa N., Caniglia S., Morale M.C., Marchetti B. Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration. Curr Aging Sci 2013, 6:45-55.
45. Eto Y., Numaguchi S., Tahara T., Rennert O.M. Multiple sulfatase deficiency (mucosulfatidosis): impaired degradation of labeled sulfated compounds in cultured skin fibroblasts in vivo. Eur J Pediatr 1980, 135:85-89.
46. Farfel-Becker T., Vitner E.B., Kelly S.L., Bame J.R., Duan J., Shinder V., Merrill A.H., Dobrenis K., Futerman A.H. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum Mol Genet 2014, 23:843-854.
47. Folkerth R.D. Abnormalities of developing white matter in lysosomal storage diseases. J Neuropathol Exp Neurol 1999, 58:887-902.
48. Fossale E., Wolf P., Espinola J.A., Lubicz-Nawrocka T., Teed A.M., Gao H., Rigamonti D., Cattaneo E., MacDonald M.E., Cotman S.L. Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neurosci 2004, 5:57.
49. Fuller M, Meikle PJ, Hopwood JJ (2006) Epidemiology of lysosomal storage diseases: an overview. In: Fabry disease: perspectives from 5 years of FOS (Mehta A et al., eds), Oxford.
50. Gan-Or Z., Giladi N., Rozovski U., Shifrin C., Rosner S., Gurevich T., Bar-Shira A., Orr-Urtreger A. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 2008, 70:2277-2283.
51. German D.C., Liang C.L., Song T., Yazdani U., Xie C., Dietschy J.M. Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 2002, 109:437-450.
52. Getty A.L., Rothberg P.G., Pearce D.A. Diagnosis of neuronal ceroid lipofuscinosis: mutation detection strategies. Expert Opin Med Diagn 2007, 1:351-362.
53. Giaume C., Leybaert L., Naus C.C., Saez J.C. Connexin and pannexin hemichannels in brain glial cells: properties, pharmacology, and roles. Front Pharmacol 2013, 4:88.
54. Giri S., Jatana M., Rattan R., Won J.S., Singh I., Singh A.K. Galactosylsphingosine (psychosine)-induced expression of cytokine-mediated inducible nitric oxide synthases via AP-1 and C/EBP: implications for Krabbe disease. FASEB J 2002, 16:661-672.
55. Goebel H.H., Schochet S.S., Jaynes M., Bruck W., Kohlschutter A., Hentati F. Progress in neuropathology of the neuronal ceroid lipofuscinoses. Mol Genet Metab 1999, 66:367-372.
56. Goker-Alpan O., Masdeu J.C., Kohn P.D., Ianni A., Lopez G., Groden C., Chapman M.C., Cropp B., Eisenberg D.P., Maniwang E.D., Davis J., Wiggs E., Sidransky E., Berman K.F. The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow. Brain 2012, 135:2440-2448.
57. Grabowski G.A., Goldblatt J., Dinur T., Kruse J., Svennerholm L., Gatt S., Desnick R.J. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Am J Med Genet 1985, 21:529-549.
58. Graler M.H. Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions. Cell Physiol Biochem 2010, 26:79-86.
59. Guerra W.F., Verity M.A., Fluharty A.L., Nguyen H.T., Philippart M. Multiple sulfatase deficiency: clinical, neuropathological, ultrastructural and biochemical studies. J Neuropathol Exp Neurol 1990, 49:406-423.
60. Halperin A., Elstein D., Zimran A. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 2006, 36:426-428.
61. Hawkins-Salsbury J.A., Cooper J.D., Sands M.S. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease). Biochim Biophys Acta 2013, 1832:1906-1909.
62. Hofmann S.L., Lee L.A., Lu J.Y., Verkruyse L.A. Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis. Neuropediatrics 1997, 28:27-30.
63. Hol E.M., Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol 2015, 32C:121-130.
64. Husain A.M., Altuwaijri M., Aldosari M. Krabbe disease: neurophysiologic studies and MRI correlations. Neurology 2004, 63:617-620.
65. Igisu H., Suzuki K. Analysis of galactosylsphingosine (psychosine) in the brain. J Lipid Res 1984, 25:1000-1006.
66. Igisu H., Suzuki K. Progressive accumulation of toxic metabolite in a genetic leukodystrophy. Science 1984, 224:753-755.
67. Incecik F., Ozbek M.N., Gungor S., Pepe S., Herguner O.M., Mungan N.O., Gungor S., Altunbasak S. Multiple sulfatase deficiency: a case series of four children. Ann Indian Acad Neurol 2013, 16:720-722.
68. Itoh H., Tanaka J., Morihana Y., Tamaki T. The fine structure of cytoplasmic inclusions in brain and other visceral organs in Sandhoff disease. Brain Dev 1984, 6:467-474.
69. Jansen A.H., Reits E.A., Hol E.M. The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front Mol Neurosci 2014, 7:73.
70. Jarvela I., Autti T., Lamminranta S., Aberg L., Raininko R., Santavuori P. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion). Ann Neurol 1997, 42:799-802.
71. Jatana M., Giri S., Singh A.K. Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. Neurosci Lett 2002, 330:183-187.
72. Jesionek-Kupnicka D., Majchrowska A., Krawczyk J., Wendorff J., Barcikowska M., Lukaszek S., Liberski P.P. Krabbe disease: an ultrastructural study of globoid cells and reactive astrocytes at the brain and optic nerves. Folia Neuropathol 1997, 35:155-162.
73. Jmoudiak M., Futerman A.H. Gaucher disease: pathological mechanisms and modern management. Br J Haematol 2005, 129:178-188.
74. Josephs K.A., Matsumoto J.Y., Lindor N.M. Heterozygous Niemann-Pick disease type C presenting with tremor. Neurology 2004, 63:2189-2190.
75. Kampine J.P., Brady R.O., Kanfer J.N., Feld M., Shapiro D. Diagnosis of Gaucher's disease and Niemann-pick disease with small samples of venous blood. Science 1967, 155:86-88.
76. Kanninen K.M., Grubman A., Caragounis A., Duncan C., Parker S.J., Lidgerwood G.E., Volitakis I., Ganio G., Crouch P.J., White A.R. Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis. Biol Open 2013, 2:635-646.
77. Karpuk N., Burkovetskaya M., Fritz T., Angle A., Kielian T. Neuroinflammation leads to region-dependent alterations in astrocyte gap junction communication and hemichannel activity. J Neurosci 2011, 31:414-425.
78. Kawashima N., Tsuji D., Okuda T., Itoh K., Nakayama K. Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis. J Neurochem 2009, 111:1031-1041.
79. Kim Y., Ramirez-Montealegre D., Pearce D.A. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc Natl Acad Sci U S A 2003, 100:15458-15462.
80. Kiselyov K., Jennigs J.J., Rbaibi Y., Chu C.T. Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 2007, 3:259-262.
81. Kodam A., Maulik M., Peake K., Amritraj A., Vetrivel K.S., Thinakaran G., Vance J.E., Kar S. Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains. Glia 2010, 58:1267-1281.
82. Kohlschutter A. Lysosomal leukodystrophies: Krabbe disease and metachromatic leukodystrophy. Handb Clin Neurol 2013, 113:1611-1618.
83. Kroemer G., Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005, 5:886-897.
84. Kuronen M., Lehesjoki A.E., Jalanko A., Cooper J.D., Kopra O. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice. Neurobiol Dis 2012, 47:444-457.
85. Lebrun A.H., Moll-Khosrawi P., Pohl S., Makrypidi G., Storch S., Kilian D., Streichert T., Otto B., Mole S.E., Ullrich K., Cotman S., Kohlschutter A., Braulke T., Schulz A. Analysis of potential biomarkers and modifier genes affecting the clinical course of CLN3 disease. Mol Med 2011, 17:1253-1261.
86. Lee S.J., Cho K.S., Koh J.Y. Oxidative injury triggers autophagy in astrocytes: the role of endogenous zinc. Glia 2009, 57:1351-1361.
87. LeVine S.M., Brown D.C. IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. J Neuroimmunol 1997, 73:47-56.
88. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Stahlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M. Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 2008, 28:468-481.
89. Lieberman A.P., Puertollano R., Raben N., Slaugenhaupt S., Walkley S.U., Ballabio A. Autophagy in lysosomal storage disorders. Autophagy 2012, 8:719-730.
90. Liu W., Tang Y., Feng J. Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 2011, 89:141-146.
91. Lloyd-Evans E., Platt F.M. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic 2010, 11:419-428.
92. Luddi A., Volterrani M., Strazza M., Smorlesi A., Rafi M.A., Datto J., Wenger D.A., Costantino-Ceccarini E. Retrovirus-mediated gene transfer and galactocerebrosidase uptake into twitcher glial cells results in appropriate localization and phenotype correction. Neurobiol Dis 2001, 8:600-610.
93. Luiro K., Kopra O., Blom T., Gentile M., Mitchison H.M., Hovatta I., Tornquist K., Jalanko A. Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. J Neurosci Res 2006, 84:1124-1138.
94. Luiro K., Yliannala K., Ahtiainen L., Maunu H., Jarvela I., Kyttala A., Jalanko A. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum Mol Genet 2004, 13:3017-3027.
95. Macaulay R.J., Lowry N.J., Casey R.E. Pathologic findings of multiple sulfatase deficiency reflect the pattern of enzyme deficiencies. Pediatr Neurol 1998, 19:372-376.
96. Macauley S.L., Pekny M., Sands M.S. The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J Neurosci 2011, 31:15575-15585.
97. Macauley S.L., Wozniak D.F., Kielar C., Tan Y., Cooper J.D., Sands M.S. Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse. Exp Neurol 2009, 217:124-135.
98. Mandlebaum F.S. A contribution to the pathology of primary splenomegaly (Gaucher type), with the report of an autopsy on a male child four and one half years of age. J Exp Med 1912, 16:797-821.
99. Matsuda N., Tanaka K. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?. J Alzheimers Dis 2010, 19:1-9.
100. Meisingset T.W., Ricca A., Neri M., Sonnewald U., Gritti A. Region- and age-dependent alterations of glial-neuronal metabolic interactions correlate with CNS pathology in a mouse model of globoid cell leukodystrophy. J Cereb Blood Flow Metab 2013, 33:1127-1137.
101. Mengel E., Klunemann H.H., Lourenco C.M., Hendriksz C.J., Sedel F., Walterfang M., Kolb S.A. Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis 2013, 8:166.
102. Micsenyi M.C., Sikora J., Stephney G., Dobrenis K., Walkley S.U. Lysosomal membrane permeability stimulates protein aggregate formation in neurons of a lysosomal disease. J Neurosci 2013, 33:10815-10827.
103. Mohri I., Taniike M., Taniguchi H., Kanekiyo T., Aritake K., Inui T., Fukumoto N., Eguchi N., Kushi A., Sasai H., Kanaoka Y., Ozono K., Narumiya S., Suzuki K., Urade Y. Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J Neurosci 2006, 26:4383-4393.
104. Montero T.D., Orellana J.A. Hemichannels: new pathways for gliotransmitter release. Neuroscience 2015, 286:45-59.
105. Myerowitz R., Lawson D., Mizukami H., Mi Y., Tifft C.J., Proia R.L. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 2002, 11:1343-1350.
106. Neudorfer O., Giladi N., Elstein D., Abrahamov A., Turezkite T., Aghai E., Reches A., Bembi B., Zimran A. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996, 89:691-694.
107. Nixon R.A. Autophagy in neurodegenerative disease: friend, foe or turncoat?. Trends Neurosci 2006, 29:528-535.
108. O'Dowd B.F., Klavins M.H., Willard H.F., Gravel R., Lowden J.A., Mahuran D.J. Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis). J Biol Chem 1986, 261:12680-12685.
109. Oh H.L., Seok J.Y., Kwon C.H., Kang S.K., Kim Y.K. Role of MAPK in ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain. Neurotoxicology 2006, 27:31-38.
110. Ohm T.G., Treiber-Held S., Distl R., Glockner F., Schonheit B., Tamanai M., Meske V. Cholesterol and tau protein - findings in Alzheimer's and Niemann Pick C's disease. Pharmacopsychiatry 2003, 36(Suppl. 2):S120-126.
111. Orellana J.A., Froger N., Ezan P., Jiang J.X., Bennett M.V., Naus C.C., Giaume C., Saez J.C. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels. J Neurochem 2011, 118:826-840.
112. Orellana J.A., Saez J.C., Bennett M.V., Berman J.W., Morgello S., Eugenin E.A. HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism. J Neurochem 2014, 128:752-763.
113. Orellana J.A., Shoji K.F., Abudara V., Ezan P., Amigou E., Saez P.J., Jiang J.X., Naus C.C., Saez J.C., Giaume C. Amyloid beta-induced death in neurons involves glial and neuronal hemichannels. J Neurosci 2011, 31:4962-4977.
114. Osellame L.D., Duchen M.R. Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration. Br J Pharmacol 2014, 171:1958-1972.
115. Osellame L.D., Rahim A.A., Hargreaves I.P., Gegg M.E., Richard-Londt A., Brandner S., Waddington S.N., Schapira A.H., Duchen M.R. Mitochondria and quality control defects in a mouse model of Gaucher disease - links to Parkinson's disease. Cell Metab 2013, 17:941-953.
116. Oswald M.J., Palmer D.N., Kay G.W., Shemilt S.J., Rezaie P., Cooper J.D. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Neurobiol Dis 2005, 20:49-63.
117. Palmer D.N., Barns G., Husbands D.R., Jolly R.D. Ceroid lipofuscinosis in sheep. II. The major component of the lipopigment in liver, kidney, pancreas, and brain is low molecular weight protein. J Biol Chem 1986, 261:1773-1777.
118. Palmer D.N., Husbands D.R., Jolly R.D. Phospholipid fatty acids in brains of normal sheep and sheep with ceroid-lipofuscinosis. Biochim Biophys Acta 1985, 834:159-163.
119. Pan T., Kondo S., Le W., Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008, 131:1969-1978.
120. Pardo C.A., Rabin B.A., Palmer D.N., Price D.L. Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis. Am J Pathol 1994, 144:829-835.
121. Patel S.C., Suresh S., Kumar U., Hu C.Y., Cooney A., Blanchette-Mackie E.J., Neufeld E.B., Patel R.C., Brady R.O., Patel Y.C., Pentchev P.G., Ong W.Y. Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. Proc Natl Acad Sci U S A 1999, 96:1657-1662.
122. Pearce D.A., Carr C.J., Das B., Sherman F. Phenotypic reversal of the btn1 defects in yeast by chloroquine: a yeast model for Batten disease. Proc Natl Acad Sci U S A 1999, 96:11341-11345.
123. Pekny M., Eliasson C., Siushansian R., Ding M., Dixon S.J., Pekna M., Wilson J.X., Hamberger A. The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes. Neurochem Res 1999, 24:1357-1362.
124. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
125. Pekny M., Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev 2014, 94:1077-1098.
126. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
127. Pereira V.G., Gazarini M.L., Rodrigues L.C., da Silva F.H., Han S.W., Martins A.M., Tersariol I.L., D'Almeida V. Evidence of lysosomal membrane permeabilization in mucopolysaccharidosis type I: rupture of calcium and proton homeostasis. J Cell Physiol 2010, 223:335-342.
128. Platt F.M., Boland B., van der Spoel A.C. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 2012, 199:723-734.
129. Platt F.M., Wassif C., Colaco A., Dardis A., Lloyd-Evans E., Bembi B., Porter F.D. Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease. Annu Rev Genomics Hum Genet 2014, 15:173-194.
130. -/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Brain Res 2004, 1023:231-242.
131. Prada C.E., Grabowski G.A. Neuronopathic lysosomal storage diseases: clinical and pathologic findings. Dev Disabil Res Rev 2013, 17:226-246.
132. Rakheja D., Narayan S.B., Bennett M.J. Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update. Curr Mol Med 2007, 7:603-608.
133. Renkawek K., Stege G.J., Bosman G.J. Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease. Neuroreport 1999, 10:2273-2276.
134. Rodriguez-Muela N., Hernandez-Pinto A.M., Serrano-Puebla A., Garcia-Ledo L., Latorre S.H., de la Rosa E.J., Boya P. Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa. Cell Death Differ 2015, 22:476-487.
135. Saez J.C., Leybaert L. Hunting for connexin hemichannels. FEBS Lett 2014, 588:1205-1211.
136. 2+ signal alterations in astrocytes from Niemann-Pick type C mice. PLoS One 2013, 8:e71361.
137. Saito Y., Suzuki K., Hulette C.M., Murayama S. Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J Neuropathol Exp Neurol 2004, 63:323-328.
138. Schneider J.S., Denaro F.J. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain. J Neuropathol Exp Neurol 1988, 47:452-458.
139. Schultz M.L., Tecedor L., Chang M., Davidson B.L. Clarifying lysosomal storage diseases. Trends Neurosci 2011, 34:401-410.
140. Settembre C., Fraldi A., Rubinsztein D.C., Ballabio A. Lysosomal storage diseases as disorders of autophagy. Autophagy 2008, 4:113-114.
141. Shyng C., Sands M.S. Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?. Biochem Soc Trans 2014, 42:1282-1285.
142. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C.M., Clark L.N., Condroyer C., De Marco E.V., Durr A., Eblan M.J., Fahn S., Farrer M.J., Fung H.C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A.E., Lee-Chen G.J., Lesage S., Marder K., Mata I.F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L.V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E.K., Tayebi N., Toda T., Troiano A.R., Tsuji S., Wittstock M., Wolfsberg T.G., Wu Y.R., Zabetian C.P., Zhao Y., Ziegler S.G. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009, 361:1651-1661.
143. Sidransky E., Samaddar T., Tayebi N. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset. Neurology 2009, 73:1424-1425. author reply 1425-1426.
144. Sinha S., Satishchandra P., Santosh V., Gayatri N., Shankar S.K. Neuronal ceroid lipofuscinosis: a clinicopathological study. Seizure 2004, 13:235-240.
145. Sleat D.E., Donnelly R.J., Lackland H., Liu C.G., Sohar I., Pullarkat R.K., Lobel P. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997, 277:1802-1805.
146. Sleat D.E., Gin R.M., Sohar I., Wisniewski K., Sklower-Brooks S., Pullarkat R.K., Palmer D.N., Lerner T.J., Boustany R.M., Uldall P., Siakotos A.N., Donnelly R.J., Lobel P. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet 1999, 64:1511-1523.
147. Smith B.R., Santos M.B., Marshall M.S., Cantuti-Castelvetri L., Lopez-Rosas A., Li G., van Breemen R., Claycomb K.I., Gallea J.I., Celej M.S., Crocker S.J., Givogri M.I., Bongarzone E.R. Neuronal inclusions of alpha-synuclein contribute to the pathogenesis of Krabbe disease. J Pathol 2014, 232:509-521.
148. Sokol J., Blanchette-Mackie J., Kruth H.S., Dwyer N.K., Amende L.M., Butler J.D., Robinson E., Patel S., Brady R.O., Comly M.E., et al. Type C Niemann-Pick disease. Lysosomal accumulation and defective intracellular mobilization of low density lipoprotein cholesterol. J Biol Chem 1988, 263:3411-3417.
149. Sriram K., Benkovic S.A., Hebert M.A., Miller D.B., O'Callaghan J.P. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?. J Biol Chem 2004, 279:19936-19947.
150. Suzuki H., Sakiyama T., Harada N., Abe M., Tadokoro M. Pathologic changes of glial cells in murine model of Niemann-Pick disease type C: immunohistochemical, lectin-histochemical and ultrastructural observations. Pediatr Int 2003, 45:1-4.
151. Suzuki K., Suzuki K. Genetic galactosylceramidase deficiency (globoid cell leukodystrophy, Krabbe disease) in different mammalian species. Neurochem Pathol 1985, 3:53-68.
152. Takamura A., Higaki K., Kajimaki K., Otsuka S., Ninomiya H., Matsuda J., Ohno K., Suzuki Y., Nanba E. Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis. Biochem Biophys Res Commun 2008, 367:616-622.
153. Tan C.C., Yu J.T., Tan M.S., Jiang T., Zhu X.C., Tan L. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging 2014, 35:941-957.
154. Tilleux S., Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 2007, 85:2059-2070.
155. Valadares E.R., Pizarro M.X., Oliveira L.R., Amorim R.H., Pinheiro T.M., Grieben U., Santos H.H., Queiroz R.R., Lopes Gde C., Godard A.L. Juvenile neuronal ceroid-lipofuscinosis: clinical and molecular investigation in a large family in Brazil. Arq Neuropsiquiatr 2011, 69:13-18.
156. Vesa J., Hellsten E., Verkruyse L.A., Camp L.A., Rapola J., Santavuori P., Hofmann S.L., Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 1995, 376:584-587.
157. Vincent A.J., Choi-Lundberg D.L., Harris J.A., West A.K., Chuah M.I. Bacteria and PAMPs activate nuclear factor kappaB and Gro production in a subset of olfactory ensheathing cells and astrocytes but not in Schwann cells. Glia 2007, 55:905-916.
158. Vitner E.B., Dekel H., Zigdon H., Shachar T., Farfel-Becker T., Eilam R., Karlsson S., Futerman A.H. Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses. Hum Mol Genet 2010, 19:3583-3590.
159. Vitner E.B., Farfel-Becker T., Eilam R., Biton I., Futerman A.H. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease. Brain 2012, 135:1724-1735.
160. Vitner E.B., Futerman A.H. Neuronal forms of Gaucher disease. Handb Exp Pharmacol 2013, 405-419.
161. Vitner E.B., Platt F.M., Futerman A.H. Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 2010, 285:20423-20427.
162. Vitner E.B., Salomon R., Farfel-Becker T., Meshcheriakova A., Ali M., Klein A.D., Platt F.M., Cox T.M., Futerman A.H. RIPK3 as a potential therapeutic target for Gaucher's disease. Nat Med 2014, 20:204-208.
163. Volders P., Van Hove J., Lories R.J., Vandekerckhove P., Matthijs G., De Vos R., Vanier M.T., Vincent M.F., Westhovens R., Luyten F.P. Niemann-Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet 2002, 109:42-51.
164. Weimer J.M., Benedict J.W., Elshatory Y.M., Short D.W., Ramirez-Montealegre D., Ryan D.A., Alexander N.A., Federoff H.J., Cooper J.D., Pearce D.A. Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis. Brain Res 2007, 1162:98-112.
165. Wenger D.A., Rafi M.A., Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat 1997, 10:268-279.
166. Wong K., Sidransky E., Verma A., Mixon T., Sandberg G.D., Wakefield L.K., Morrison A., Lwin A., Colegial C., Allman J.M., Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 2004, 82:192-207.
167. Wu Y.P., Mizugishi K., Bektas M., Sandhoff R., Proia R.L. Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease. Hum Mol Genet 2008, 17:2257-2264.
168. Wu Y.P., Proia R.L. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci U S A 2004, 101:8425-8430.
169. Xiong J., Kielian T. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype. J Neurochem 2013, 127:245-258.
170. Yan X., Yang F., Lukas J., Witt M., Wree A., Rolfs A., Luo J. Hyperactive glial cells contribute to axonal pathologies in the spinal cord of Npc1 mutant mice. Glia 2014, 62:1024-1040.
171. Yu W., Gong J.S., Ko M., Garver W.S., Yanagisawa K., Michikawa M. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem 2005, 280:11731-11739.
172. Zervas M., Dobrenis K., Walkley S.U. Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 2001, 60:49-64.
173. Zervas M., Somers K.L., Thrall M.A., Walkley S.U. Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr Biol 2001, 11:1283-1287.
174. -/- mice. J Neurosci Res 2008, 86:2848-2856.
175. Zhou S.Y., Xu S.J., Yan Y.G., Yu H.M., Ling S.C., Luo J.H. Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C. Hippocampus 2011, 21:212-219.